Mirae Asset Global Etfs Holdings Ltd. Arcellx, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,774 shares of ACLX stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,774
Previous 22,755
13.27%
Holding current value
$2.27 Million
Previous $1.26 Million
71.47%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACLX
# of Institutions
205Shares Held
44.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$352 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$342 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$330 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$309 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$217 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.86B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...